Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. New York
    4. ›
  4. 02142
    5. ›
  5. RENEGADE THERAPEUTICS INC.

RENEGADE THERAPEUTICS INC.

Company claim

Is this your business?

Get access!

Company Details

Name: RENEGADE THERAPEUTICS INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Inactive
Date of registration: 18 Dec 2001 (24 years ago)
Date of dissolution: 23 Oct 2007
Entity Number: 2710101
ZIP code: 02142
County: New York
Place of Formation: Delaware
Address: ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, United States, 02142
Principal Address: 405 LEXINGTON AVE 54TH FLR, NEW YORK, NY, United States, 10174

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, United States, 02142

Agent

Name Role
REGISTERED AGENT REVOKED Agent

Chief Executive Officer

Name Role Address
MARTIN VOGELBAUM Chief Executive Officer 405 LEXINGTON AVE 54TH FLR, NEW YORK, NY, United States, 10174

History

Start date End date Type Value
2001-12-18 2007-10-23 Address 80 STATE STREET, ALBANY, NY, 12207, 2543, USA (Type of address: Registered Agent)
2001-12-18 2007-10-23 Address 80 STATE STREET, ALBANY, NY, 12207, 2543, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
071023000985 2007-10-23 SURRENDER OF AUTHORITY 2007-10-23
031211002722 2003-12-11 BIENNIAL STATEMENT 2003-12-01
011218000591 2001-12-18 APPLICATION OF AUTHORITY 2001-12-18

Trademarks Section

Serial Number:
97688772
Mark:
RENEGADE THERAPEUTICS CORP.
Status:
ABANDONED - EXPRESS
Mark Type:
TRADEMARK
Application Filing Date:
2022-11-22
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
RENEGADE THERAPEUTICS CORP.
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Pharmaceutical preparations for use in the treatment of autoimmune diseases, multiple sclerosis, Crohn's disease, ulcerative colitis, inflammatory disorders, neurological disorders, neurodegenerative disorders, and Epstein-Barr virus associated lymphoproliferative disorders
First Use:
2021-11-01
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
78079749
Mark:
RENEGADE THERAPEUTICS
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2001-08-17
Mark Drawing Type:
Typeset: Word(s)/letter(s)/number(s)
Mark Literal Elements:
RENEGADE THERAPEUTICS
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Nucleic acid assays; gene expression assays; gene transcription assays, all for clinical or medical use
International Classes:
005 - Primary Class
Class Status:
Active
Serial Number:
78079746
Mark:
RENEGADE THERAPEUTICS
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2001-08-17
Mark Drawing Type:
Typeset: Word(s)/letter(s)/number(s)
Mark Literal Elements:
RENEGADE THERAPEUTICS
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Nucleic acid assays; gene expression assays; gene transcription assays, all for scientific or research use
International Classes:
001 - Primary Class
Class Status:
Active
Serial Number:
78079748
Mark:
RENEGADE
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2001-08-17
Mark Drawing Type:
Typeset: Word(s)/letter(s)/number(s)
Mark Literal Elements:
RENEGADE
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Nucleic acid assays; gene expression assays; gene transcription assays, all for scientific or research use
International Classes:
001 - Primary Class
Class Status:
Active
Serial Number:
78079750
Mark:
RENEGADE
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
TRADEMARK
Application Filing Date:
2001-08-17
Mark Drawing Type:
Typeset: Word(s)/letter(s)/number(s)
Mark Literal Elements:
RENEGADE
USPTO Link:
View Trademark Status and Document Retrieval (TSDR)

Goods And Services

For:
Nucleic acid assays; gene expression assays; gene transcription assays, all for clinical or medical use
International Classes:
005 - Primary Class
Class Status:
Active

Court Cases

Court Case Summary

Filing Date:
2023-01-12
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Trademark

Parties

Party Name:
RENEGADE THERAPEUTICS INC.
Party Role:
Defendant
Party Name:
RENAGADE THERAPEUTICS MANAGEME
Party Role:
Plaintiff

Reviews Leave a review

This company hasn't received any reviews.

Related by officers

THE CORPORATION

ARSHIA DESIGNS INC. AAA VACUUM CORP. ATLANTICA TELECOM, INC. MISTY SPORTSWEAR, INC. FAT JAMS ELECTRONICS INC. CROQUEMBOUCHE, INC. LONG BEACH PEDIATRIC GROUP, P.C. LAW OFFICES OF JOSEPH A. GRECO, P.C. TEREZ, INC. 732 CINNAMON BEACH INC.

REGISTERED AGENT REVOKED

TECHSPACE NEW YORK INC. BH SALES & MARKETING, LLC KOC FUNDING CORPORATION TRANS POWER MAURITIUS DHB INC. BALDWIN REALTY CONSULTANTS, INC. SUDO COACHING LLC ARLON OPPORTUNITIES INVESTORS GP LLC KARL ALEPH INC. SHOPPINGTOWN MALL, L.P.

Related by address

ONE BROADWAY, 14TH FLOOR, CAMBRIDGE, MA, United States, 02142

BIBSMA LLC BLUE EGG (DELAWARE) ROCKEFELLER CONSULTING TECHNOLOGY INTEGRATION, INC. TOKAI PHARMACEUTICALS, INC. STEINBONES LLC

405 LEXINGTON AVE 54TH FLR, NEW YORK, NY, United States, 10174

GSB PODIUM ADVISORS, LLC

Date of last update: 30 Mar 2025

Sources: New York Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 bizyork.com, Part of Big Data Integrated